Maravai LifeSciences Holdings, Inc. (MRVI) Gross margin 2019–2025
Maravai LifeSciences Holdings, Inc. (MRVI) gross margin by fiscal year — reported gross profit divided by reported revenue.
18.3%FY2025 · since FY2019: 53.3% → 18.3%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 18.3% | -23.5 pp |
| FY2024 | 41.8% | -6.7 pp |
| FY2023 | 48.5% | -32.3 pp |
| FY2022 | 80.9% | -1.5 pp |
| FY2021 | 82.4% | +10.4 pp |
| FY2020 | 72.0% | +18.7 pp |
| FY2019 | 53.3% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More MRVI financial trends
MRVI RevenueMRVI Net incomeMRVI Net marginMRVI Gross profitMRVI Operating incomeMRVI Operating marginMRVI Operating cash flowMRVI Free cash flowMRVI Capital expendituresMRVI Return on equityMRVI Stock buybacksMRVI Dividends paidMRVI Total assetsMRVI Total liabilitiesMRVI Shareholders’ equityMRVI overview →